Are We Using Too Much Triamcinolone Acetonide for Intralesional Keloid Therapy?

Download PDF File

METRICS

Are We Using Too Much Triamcinolone Acetonide for Intralesional Keloid Therapy? 

Email Article

Nina Zamani¹, M.Sc., Michael Tirgan², M.D., Akash Gunjan^1*, Ph.D.

Affiliations:

1. Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306-2300, USA
2. Keloid Research Foundation, New York, NY, 10023, USA.

Corresponding author:

Akash Gunjan, Ph.D.
Department of Biomedical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306-2300, USA

Email: akash.gunjan@med.fsu.edu

Funding sources: None.

Conflicts of interest: None declared.

Institutional review board approval: Are We Using Too Much Triamcinolone Acetonide for Intralesional Keloid Therapy? Correlation between in vitro and in vivo data.

Running Title

Integrated Surgical Debulking Combined with Laser and Radiotherapy (SLCR) for Complex Keloids

Institutional review board approval: This study was deemed exempt by the Florida State University Institutional Review Board

Word Count

482 words

Keywords: intralesional corticosteroid (ILCS), keloid, keloid fibroblast, steroid, triamcinolone acetonide (TA); intralesional TA (ILTA)